Pricing Log in Create free account

Autolus Therapeutics PLC Sponsored ADR (AUTL) vs MapLight Therapeutics, Inc. (MPLT)

Autolus Therapeutics PLC Sponsored ADR and MapLight Therapeutics, Inc. are both Biotechnology companies. Autolus Therapeutics PLC Sponsored ADR and MapLight Therapeutics, Inc. are of similar size ($490.7M and $481.8M). MapLight Therapeutics, Inc. has the higher net margin (0.00% vs −238.7%) and the lower return on invested capital (−348.4% vs 0.00%). Across the 13 metrics below, MapLight Therapeutics, Inc. leads on 8 and Autolus Therapeutics PLC Sponsored ADR on 5.

Valuation

Metric AUTL MPLT Biotechnology median
P/E n/m n/m 8.56
P/S 3.95 n/m 10.17
P/B 6.19 1.12 2.34
Price to free cash flow n/m n/m 20.42
EV/EBITDA n/m n/m 0.69
EV/Sales 2.88 n/m 9.64
Earnings yield (60.92%) (491.98%) (29.41%)
Free cash flow yield (54.82%) (44.82%) (23.50%)

Profitability

Metric AUTL MPLT Biotechnology median
Gross margin 15.66% — 65.16%
Operating margin (210.78%) 0.00% 0.00%
Net margin (238.66%) 0.00% 0.00%
Free cash flow margin (198.26%) 0.00% 0.00%
Return on equity (133.00%) (297.18%) (56.66%)
Return on assets (46.15%) (124.79%) (49.22%)
Return on invested capital 0.00% (348.44%) 0.00%

Growth

Metric AUTL MPLT Biotechnology median
Revenue growth (TTM) 193.29% — 5.64%
EPS growth (last fiscal year) (25.58%) 82.39% 30.08%
Revenue growth, 5-year CAGR 113.11% — 9.41%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric AUTL MPLT Biotechnology median
Debt to equity 1.04 0.00 0.00
Current ratio 4.89 16.52 4.72
Net debt to EBITDA 1.16 1.79 0.96

Dividend

Metric AUTL MPLT Biotechnology median
Dividend yield — — 0.08%
Payout ratio — — —

Size

Metric AUTL MPLT Biotechnology median
Market cap 481.75m 490.73m 151.40m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack